Graphite Bio (NASDAQ:GRPH – Get Free Report) and Talaris Therapeutics (NASDAQ:TALS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Analyst Ratings This is a breakdown of […]
Talaris Therapeutics (NASDAQ:TALS – Get Rating) and Cardiol Therapeutics (NASDAQ:CRDL – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, risk, profitability, analyst recommendations and dividends. Risk & Volatility Talaris Therapeutics has a beta of […]
Talaris Therapeutics (NASDAQ:TALS – Get Rating) and Rubius Therapeutics (NASDAQ:RUBY – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership. Valuation and Earnings This table compares Talaris Therapeutics and […]
BioNTech (NASDAQ:BNTX – Get Rating) and Talaris Therapeutics (NASDAQ:TALS – Get Rating) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, institutional ownership, valuation and profitability. Institutional and Insider Ownership 14.4% of BioNTech shares are owned by […]
Talaris Therapeutics (NASDAQ:TALS – Get Rating) is one of 254 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its competitors? We will compare Talaris Therapeutics to similar companies based on the strength of its institutional ownership, profitability, risk, valuation, earnings, analyst recommendations and dividends. Profitability This table compares […]